Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 306

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 306
---
 Common Stock determined according to the
formula set forth in the Pre-Funded Warrant.

Exercise Limitation

In general, a holder will
not have the right to exercise any portion of a Pre-Funded Warrant if the holder (together with its Attribution Parties (as defined in
the Pre-Funded Warrant)) would beneficially own in excess of 4.99% or 9.99%, at the election of the holder, of the number of shares of
our Common Stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance
with the terms of the Pre-Funded Warrant. However, any holder may increase or decrease such percentage to any other percentage not in
excess of 9.99% upon notice to us, provided, that any increase in this limitation will not be effective until 61 days after such notice
from the holder to us and such increase or decrease will apply only to the holder providing such notice.

Transferability

Subject to applicable laws,
a Pre-Funded Warrant may be transferred at the option of the holder upon surrender of the Pre-Funded Warrant to us together with the
appropriate instruments of transfer.

<div align='center'>179</div>

Fractional Shares

No fractional shares of
Common Stock will be issued upon the exercise of the Pre-Funded Warrants. Rather, the number of shares of Common Stock to be issued will,
at our election, either be rounded up to the nearest whole number or we will pay a cash adjustment in respect of such final fraction
in an amount equal to such fraction multiplied by the exercise price.

Trading Market

There is no trading market
available for the Pre-Funded Warrants on any securities exchange or nationally recognized trading system.

Fundamental Transactions

If a “Fundamental
Transaction” occurs while the Pre-Funded Warrants are outstanding (which includes, but is not limited to, merger transactions or
a sale of substantially all of the company’s assets), then if holders of the Common Stock are given any choice as to the securities,
cash or property to be received in a Fundamental Transaction (as defined in the Pre-Funded Warrant), then the holder will be given the
same choice as to the consideration it receives upon any exercise of either the Pre-Funded Warrants following such Fundamental Transaction.

Right as a Stockholder

Except as otherwise provided
in the Pre-Funded Warrants or by virtue of such holder’s ownership of shares of our Common Stock, the holders of the Pre